GSK (GSK) News Today GBX 1,308.50 -13.50 (-1.02%) (As of 12/20/2024 12:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainability All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period GSK plc (LON:GSK) Given Consensus Rating of "Moderate Buy" by AnalystsGSK plc (LON:GSK - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven analysts that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy ratingDecember 20 at 3:43 AM | marketbeat.comCorrection: GSK subsidiary ViiV Healthcare and Colombian regulatorsDecember 18 at 3:48 AM | ft.comGSK’s Cancer Drug Jemperli Nears EU Marketing ExpansionDecember 17, 2024 | msn.comGSK’s lung cancer therapy gains EMA PRIME designationDecember 17, 2024 | finance.yahoo.comGSK announces EMA granted PRIME Designation for GSK5764227December 16, 2024 | markets.businessinsider.com‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouseDecember 16, 2024 | msn.comJPMorgan Chase & Co. Reiterates Underweight Rating for GSK (LON:GSK)December 13, 2024 | americanbankingnews.comGoldman Sachs Sticks to Its Hold Rating for GlaxoSmithKline (GSK)December 11, 2024 | markets.businessinsider.comGSK Is Doing The Right Things But Can't Catch A Break - Rating DowngradeDecember 11, 2024 | seekingalpha.comRelation-GSK to drive fibrotic and osteoarthritis developmentsDecember 11, 2024 | finance.yahoo.comJPMorgan Chase & Co. Reaffirms "Underweight" Rating for GSK (LON:GSK)JPMorgan Chase & Co. reiterated an "underweight" rating on shares of GSK in a report on Wednesday.December 11, 2024 | marketbeat.comRgenta Therapeutics Announces Strategic Alliance with GSK to Develop RNA-Targeted Small Molecule Splice ModulatorsDecember 4, 2024 | finance.yahoo.comBerenberg Bank Sticks to Its Buy Rating for GlaxoSmithKline (GSK)December 2, 2024 | markets.businessinsider.comGSK: Liquid Meningitis Vaccine Authorised in EUNovember 27, 2024 | marketwatch.comGSK eyes up combo approval for previously withdrawn myeloma drugNovember 25, 2024 | finance.yahoo.comGSK gains approval in Japan for extended indication of RSV vaccineNovember 25, 2024 | finance.yahoo.comGSK's Blenrep combinations accepted for review by US FDANovember 25, 2024 | lse.co.ukGSK :FDA Accepts Blenrep Combination For Review In Treatment Of Relapsed/Refractory Multiple MyelomaNovember 25, 2024 | markets.businessinsider.comGSK plc (LON:GSK) Receives Consensus Rating of "Moderate Buy" from BrokeragesShares of GSK plc (LON:GSK - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seven analysts that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five haNovember 25, 2024 | marketbeat.comGSK announces Japan’s MHLW approved application to extend indication of ArexvyNovember 23, 2024 | markets.businessinsider.comTOP NEWS: GSK's Arexvy RSV vaccine approved in Japan for adults 50-59November 22, 2024 | lse.co.ukLONDON BRIEFING: GSK approval; Games Workshop trades ahead of forecastNovember 22, 2024 | lse.co.ukGSK Plc Announces Regulatory Expansion For Arexvy In Japan To Include Adults Aged 50-59November 22, 2024 | markets.businessinsider.comGSK announces phase III trial of linerixibat met primary endpointNovember 20, 2024 | markets.businessinsider.comDown 28%! What’s going on with GSK’s share price?November 20, 2024 | uk.finance.yahoo.comGSK reports positive Phase 3 results for linerixibat in PBC itchingNovember 19, 2024 | msn.comGSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some PatientsNovember 19, 2024 | finance.yahoo.comFTSE 100 Live 15 November: GDP disappoints, fresh GSK slump offsets Land Securities upgradeNovember 16, 2024 | msn.comGSK reports positive outcomes from Phase III multiple myeloma treatment trialNovember 16, 2024 | msn.comGSK hails progress for withdrawn blood cancer drugNovember 14, 2024 | ft.comGSK’s Withdrawn Blood Cancer Drug Reduced Risk of Death in TrialNovember 14, 2024 | bloomberg.comGSK Reports Positive Headline Results From DREAMM-7 Phase III TrialNovember 14, 2024 | markets.businessinsider.comGSK plc (LON:GSK) Insider Julie Brown Purchases 8 SharesNovember 13, 2024 | insidertrades.comGSK (LON:GSK) Hits New 1-Year Low - Should You Sell?GSK (LON:GSK) Reaches New 1-Year Low - Should You Sell?November 12, 2024 | marketbeat.comGSK price target lowered to 1,450 GBp from 1,550 GBp at BarclaysNovember 9, 2024 | markets.businessinsider.comGSK CEO addresses declining trust in vaccines following Trump re-electionNovember 6, 2024 | finance.yahoo.comGSK’s RSV vaccine approved in Canada for adults aged 50 to 59November 6, 2024 | finance.yahoo.comGlaxoSmithKline (GSK) Receives a Buy from BernsteinOctober 31, 2024 | markets.businessinsider.comGSK plc (LON:GSK) Receives Average Recommendation of "Moderate Buy" from BrokeragesGSK plc (LON:GSK - Get Free Report) has earned an average rating of "Moderate Buy" from the seven brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have assigned a buyOctober 31, 2024 | marketbeat.comGSK plc (LON:GSK) Insider Buys £99,671 in StockOctober 31, 2024 | insidertrades.comGSK plc (LON:GSK) to Issue GBX 15 DividendGSK plc (LON:GSK) announced a dividend on Wednesday, October 30th. Shareholders of record on Thursday, November 14th will be given a dividend of GBX 15 ($0.19) per share on Thursday, January 9th. This represents a yield of 1.03%. The ex-dividend date is Thursday, November 14th. The official announcement can be viewed at this link.October 30, 2024 | marketbeat.comBritish pharmaceutical company GSK reports drop in Q3 pre-tax profitOctober 30, 2024 | msn.comGSK Profit Rises on HIV, Cancer Treatments But Sales Slip on Weak U.S. Vaccine DemandOctober 30, 2024 | msn.comGSK reiterates guidance as HIV and cancer drug demand offset vaccine weaknessOctober 30, 2024 | msn.comGSK’s Vaccine Sales Drop, Taking the Shine off Strong ProfitOctober 30, 2024 | bloomberg.comGSK cuts 2024 vaccine sales forecast for second time this yearOctober 30, 2024 | msn.comGSK to acquire CMG1A46 from Chimagen BiosciencesOctober 29, 2024 | markets.businessinsider.comGSK inks deal to buy lupus therapy from Chimagen for USD300 millionOctober 29, 2024 | lse.co.ukGSK Inks Lupus Deal With Chinese Biotech for Up to $850 MillionOctober 29, 2024 | msn.comGraham Parry Issues ‘Sell’ Rating on GlaxoSmithKline Amid Declining Vaccine Sales and EPS Forecast CutsOctober 29, 2024 | markets.businessinsider.com Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin GSK Media Mentions By Week GSK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼-0.190.60▲Average Medical News Sentiment GSK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼66▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AZN News Today HCM News Today ITH News Today GRI News Today INDV News Today BMY News Today GPH News Today IGC News Today ARTL News Today PHAR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:GSK) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GSK Stock Alerts